World's Best Scientists 2026 revealed!
Catherine Sautès-Fridman

Catherine Sautès-Fridman

D-Index & Metrics

Immunology

D-Index
84
Citations
41555
World Ranking
1335
National Ranking
49

Medicine

D-Index
84
Citations
41584
World Ranking
14839
National Ranking
479

Catherine Sautès-Fridman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Catherine Sautès-Fridman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 183 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Catherine Sautès-Fridman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Catherine Sautès-Fridman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Catherine Sautès-Fridman is affiliated with Université Paris Cité in France and has a research focus centered on cancer immunotherapy and immune response mechanisms. Their work spans multiple fields including Medicine and Immunology and Microbiology, with a significant number of publications related to Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, and Cancer Research.

The scientist's main research topics include cancer immunotherapy and biomarkers, renal cell carcinoma treatment, immunotherapy and immune responses, immune cell function and interaction, CAR-T cell therapy research, immune cells in cancer, and ferroptosis and cancer prognosis.

Frequent coauthors collaborating with Catherine Sautès-Fridman include Wolf H. Fridman, Maxime Meylan, Yann Vano, Antoine Bougoüin, and Cheng-Ming Sun. These collaborations reflect an active engagement in projects related to tumor immunology and therapeutic response.

Common venues where their research has been published include Annals of Oncology, Journal of Clinical Oncology, Cancer Research, Cancer Immunology Research, and bioRxiv (Cold Spring Harbor Laboratory).

Significant recent publications by Catherine Sautès-Fridman include:

  • B cells and tertiary lymphoid structures promote immunotherapy response (2020, Nature)
  • B cells are associated with survival and immunotherapy response in sarcoma (2020, Nature)
  • Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer (2022, Immunity)
  • The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies (2020, Frontiers in Immunology)
  • B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome (2022, Nature Reviews Clinical Oncology)

Best Publications

  • The immune contexture in human tumours: impact on clinical outcome

    Wolf Herman Fridman;Franck Pagès;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Jérôme Galon

  • Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

    Etienne Becht;Nicolas A. Giraldo;Nicolas A. Giraldo;Nicolas A. Giraldo;Laetitia Lacroix;Laetitia Lacroix;Laetitia Lacroix;Bénédicte Buttard;Bénédicte Buttard;Bénédicte Buttard

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • The immune contexture in cancer prognosis and treatment

    Wolf H Fridman;Laurence Zitvogel;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Guido Kroemer

  • B cells are associated with survival and immunotherapy response in sarcoma.

    Florent Petitprez;Aurélien de Reyniès;Emily Z. Keung;Tom Wei Wu Chen

  • Tertiary lymphoid structures in the era of cancer immunotherapy

    Catherine Sautès-Fridman;Florent Petitprez;Julien Calderaro;Julien Calderaro;Wolf Herman Fridman

  • Immune infiltration in human tumors: a prognostic factor that should not be ignored.

    Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

    Claire Germain;Sacha Gnjatic;Fella Tamzalit;Samantha Knockaert

  • The clinical role of the TME in solid cancer.

    Nicolas A Giraldo;Rafael Sanchez-Salas;J David Peske;Yann Vano

  • Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.

    Jérémy Goc;Claire Germain;Thi Kim Duy Vo-Bourgais;Audrey Lupo

  • Tertiary lymphoid structures in cancer and beyond

    Marie-Caroline Dieu-Nosjean;Marie-Caroline Dieu-Nosjean;Jérémy Goc;Jérémy Goc;Nicolas A. Giraldo;Nicolas A. Giraldo;Catherine Sautès-Fridman;Catherine Sautès-Fridman

  • The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.

    Florent Petitprez;Maxime Meylan;Aurélien de Reyniès;Catherine Sautès-Fridman

  • Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

    Etienne Becht;Aurélien de Reyniès;Nicolas A. Giraldo;Camilla Pilati

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

    Sophia Platonova;Julien Cherfils-Vicini;Diane Damotte;Lucile Crozet

  • Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

    Nicolas Giraldo;Nicolas Giraldo;Nicolas Giraldo;Etienne Becht;Etienne Becht;Etienne Becht;Franck Pages;Georgios P Skliris

  • Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

    Lucile Vanhersecke;Maxime Brunet;Jean-Philippe Guégan;Christophe Rey

  • The structure of a human type III Fcgamma receptor in complex with Fc

    Sergei Radaev;Shawn Motyka;Wolf-Herman Fridman;Catherine Sautes-Fridman

  • Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.

    Fabrice Benchetrit;Arnaud Ciree;Virginie Vives;Guy Warnier

  • Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates

    Wolf Herman Fridman;Jérôme Galon;Franck Pagès;Eric Tartour

Frequent Co-Authors

Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Isabelle Cremer
Isabelle Cremer Sorbonne University
Diane Damotte
Diane Damotte Hôtel-Dieu de Paris
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Guido Kroemer
Guido Kroemer Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Marie-Agnès Dragon-Durey
Marie-Agnès Dragon-Durey Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, advancing your education through specialized nursing programs can open doors to diverse healthcare roles. Transitioning into advanced practice roles often involves certifications such as acute care np certification, which prepares nurse practitioners to manage complex patient conditions in acute settings. This credential can be pivotal for immunology professionals working in critical care or infectious disease units.

If you're looking to fast-track your nursing career, exploring accelerated nurse practitioner programs offers an efficient path to advanced practice. These programs often combine rigorous training with clinical experience, making them ideal for students who already hold a non-nursing degree.

For beginners entering the field, 12-month accelerated nursing programs online for non nurses provide an opportunity to quickly obtain essential nursing qualifications. These programs cater specifically to non-nurses seeking to establish foundational healthcare expertise promptly.

Additionally, accelerated bsn programs for non nurses are a popular choice for students aiming to earn a Bachelor of Science in Nursing degree efficiently. These pathways can serve as stepping stones toward advanced immunology careers in research, clinical practice, or public health.

Best Scientists Citing Catherine Sautès-Fridman

Trending Scientists

Recently Published Articles